Jiye Zhu

5.0k total citations · 1 hit paper
111 papers, 2.4k citations indexed

About

Jiye Zhu is a scholar working on Hepatology, Surgery and Molecular Biology. According to data from OpenAlex, Jiye Zhu has authored 111 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Hepatology, 34 papers in Surgery and 31 papers in Molecular Biology. Recurrent topics in Jiye Zhu's work include Hepatocellular Carcinoma Treatment and Prognosis (20 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (14 papers) and Liver Disease and Transplantation (13 papers). Jiye Zhu is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (20 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (14 papers) and Liver Disease and Transplantation (13 papers). Jiye Zhu collaborates with scholars based in China, United States and Denmark. Jiye Zhu's co-authors include Xiang Xiao, Hengkang Liu, Jinghui Cheng, Ruidong Xue, Qi Cao, Zhao Li, Ning Zhang, Christopher S. Chen, Lee‐Yuan Liu‐Chen and Li Zhao and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Jiye Zhu

100 papers receiving 2.3k citations

Hit Papers

Liver tumour immune micro... 2022 2026 2023 2024 2022 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Liver tumour immune microenvironment subtypes and neutrophil heterogeneity
    2022 494 citations Ruidong Xue, Qiming Zhang et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiye Zhu China 23 916 559 421 375 326 111 2.4k
Giuseppe Portella Italy 37 2.0k 2.2× 1.3k 2.3× 460 1.1× 151 0.4× 379 1.2× 130 4.5k
Paolo Fagone Italy 36 1.5k 1.6× 508 0.9× 1.1k 2.7× 95 0.3× 300 0.9× 121 3.7k
Giuseppe Servillo Italy 22 903 1.0× 256 0.5× 549 1.3× 165 0.4× 187 0.6× 50 2.0k
Sheng Xia China 27 992 1.1× 319 0.6× 738 1.8× 64 0.2× 262 0.8× 98 2.3k
Yutaka Tomoda Japan 36 1.1k 1.2× 629 1.1× 579 1.4× 78 0.2× 236 0.7× 253 4.2k
Luis G. Guijarro Spain 25 948 1.0× 274 0.5× 206 0.5× 67 0.2× 170 0.5× 127 2.3k
Shing Chuan Hooi Singapore 30 1.8k 2.0× 523 0.9× 157 0.4× 67 0.2× 722 2.2× 65 2.9k
Hui Tang China 28 1.1k 1.2× 217 0.4× 149 0.4× 89 0.2× 569 1.7× 119 2.6k
Matthew E. Roth United States 13 1.4k 1.6× 1.3k 2.3× 377 0.9× 142 0.4× 267 0.8× 19 3.0k
Toshihito Tanahashi Japan 29 1.3k 1.5× 291 0.5× 625 1.5× 110 0.3× 693 2.1× 99 2.9k

Countries citing papers authored by Jiye Zhu

Since Specialization
Citations

This map shows the geographic impact of Jiye Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiye Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiye Zhu more than expected).

Fields of papers citing papers by Jiye Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiye Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiye Zhu. The network helps show where Jiye Zhu may publish in the future.

Co-authorship network of co-authors of Jiye Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Jiye Zhu. A scholar is included among the top collaborators of Jiye Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiye Zhu. Jiye Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, Jiye, et al.. (2025). Two ANCF Hyperelastic Reduced Beam Elements Based on Neo-Hookean and Yeoh Models. International Journal of Structural Stability and Dynamics. 1 indexed citations
2.
Wei, Pengcheng, et al.. (2024). Multi-omics-driven discovery of invasive patterns and treatment strategies in CA19-9 positive intrahepatic cholangiocarcinoma. Journal of Translational Medicine. 22(1). 1031–1031. 7 indexed citations
3.
Zheng, Jiaxi, Yang Wang, Li Zhao, et al.. (2024). Augmentation of hepatocellular carcinoma malignancy by annexin A5 through modulation of invasion and angiogenesis. Scandinavian Journal of Gastroenterology. 59(8). 939–953. 1 indexed citations
4.
Cheng, Qian, et al.. (2023). NDRG1 facilitates self-renewal of liver cancer stem cells by preventing EpCAM ubiquitination. British Journal of Cancer. 129(2). 237–248. 10 indexed citations
5.
Xue, Ruidong, Qiming Zhang, Qi Cao, et al.. (2022). Liver tumour immune microenvironment subtypes and neutrophil heterogeneity. Nature. 612(7938). 141–147. 494 indexed citations breakdown →
6.
Zhang, Haojian, et al.. (2021). PESV represses non-small cell lung cancer cell malignancy through circ_0016760 under hypoxia. Cancer Cell International. 21(1). 628–628. 5 indexed citations
7.
Xiao, Xiang, Ziyang Liu, Chong Zhang, et al.. (2021). IDH Mutation Subgroup Status Associates with Intratumor Heterogeneity and the Tumor Microenvironment in Intrahepatic Cholangiocarcinoma. Advanced Science. 8(17). e2101230–e2101230. 48 indexed citations
8.
Zhao, Li, et al.. (2020). Therapeutic Efficacy of Sorafenib in Patients with Hepatocellular Carcinoma Recurrence After Liver Transplantation: A Systematic Review and Meta-Analysis. The Turkish Journal of Gastroenterology. 32(1). 30–41. 13 indexed citations
9.
10.
Li, Zhao, et al.. (2019). Stromal morphological changes and immunophenotypic features of precancerous lesions and hepatocellular carcinoma. Journal of Clinical Pathology. 72(4). 295–303. 4 indexed citations
11.
Cui, Xiao, et al.. (2015). Prognostic value of glypican-3 in patients with HBV-associated hepatocellular carcinoma after liver transplantation. Hepatobiliary & pancreatic diseases international. 14(2). 157–163. 19 indexed citations
12.
Cui, Hongyuan, Zhao Li, & Jiye Zhu. (2014). Correlation of the nutritional status with liver function and clinical outcomes in surgically treated liver cancer patients. 22(2). 82–86. 1 indexed citations
13.
Gao, Jie, et al.. (2014). Clinical efficacy of liver transplantation for liver cirrhosis and portal hypertension. Zhōnghuá xiāohuà wàikē zázhì/Zhonghua xiaohua waike zazhi. 13(9). 683–686. 1 indexed citations
14.
15.
Li, Xinyu, et al.. (2013). De novo neoplasms after liver transplantation: a clinical study. Zhonghua gan-dan waike zazhi. 19(2). 102–104. 1 indexed citations
16.
Li, Xinyu, et al.. (2012). Metabolic syndrome in liver transplant recipients:prevalence and risk factors. Zhonghua putong waike zazhi. 27(1). 8–11. 1 indexed citations
17.
Li, Guangming, et al.. (2012). The initial application of sorafenib in liver transplantation patients of primary hepatic carcinoma exceeding Milan criteria. Zhonghua gan-dan waike zazhi. 18(5). 350–353. 1 indexed citations
18.
19.
Zhu, Jiye, Carsten Obel, Olga Basso, & Jørn Olsen. (2010). Parental infertility and developmental coordination disorder in children. Human Reproduction. 25(4). 908–913. 14 indexed citations
20.
Wang, Xuehao, Lünan Yan, Feng Zhang, et al.. (2006). Early experiences on living donor liver transplantation in China: multicenter report. Chinese Medical Journal. 119(12). 1003–1009. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giuseppe Portella Breakdown of academic impact, for papers by Paolo Fagone Breakdown of academic impact, for papers by Giuseppe Servillo Breakdown of academic impact, for papers by Sheng Xia Breakdown of academic impact, for papers by Yutaka Tomoda Breakdown of academic impact, for papers by Luis G. Guijarro Breakdown of academic impact, for papers by Shing Chuan Hooi Breakdown of academic impact, for papers by Hui Tang Breakdown of academic impact, for papers by Matthew E. Roth Breakdown of academic impact, for papers by Toshihito Tanahashi
Rankless by CCL
2026